Detalhe da pesquisa
1.
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease.
Am J Respir Crit Care Med
; 203(2): 245-249, 2021 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33252997
2.
Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study.
Respir Med
; 172: 106146, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32971360